Definition

A radioactive drug used to treat adults with PSMA-positive prostate cancer that has spread to other parts of the body and has not responded to treatments that lower testosterone levels. It is used in patients whose cancer has been treated with an androgen receptor inhibitor and a type of anticancer drug called a taxane. Lutetium Lu 177 vipivotide tetraxetan binds to a protein called PSMA, which is found on some prostate cancer cells. It gives off radiation that may kill the cancer cells. Lutetium Lu 177 vipivotide tetraxetan is a type of radioconjugate. Also called Pluvicto.